I bought fat jab on Facebook for £150 then blacked out & almost died – when docs told me what was in it I was horrified
TEARS prick Michelle Sword's eyes as she scrolls through photos of herself in hospital, tubes snaking in and out of her body.
The 45-year-old wasn't there for a routine operation - she was fighting for her life after unknowingly injecting herself with fake Ozempic bought from a Facebook seller.
6
6
6
Now, two years on, the mum from Carterton, Oxon, wants to warn others about the dangers of "skinny jabs".
She tells Sun Club: 'I'd never go anywhere near skinny jabs again - fake or otherwise. Being skinny isn't worth dying for.'
Michelle bought an £150 Ozempic pen through an online pharmacy site three years ago after she put on two stone following the breakdown of her marriage.
'I'd always been a size 8-10 but the weight had been slowly creeping on as I turned to comfort eating,' she explains.
'I no longer recognised myself when I looked in the mirror. I was in a bad place and had been gorging on lots of greasy takeaways and drinking far too much alcohol.'
Michelle said much of the instructions were in a foreign language but it said to inject once a week.
'The jabs really worked – my appetite simply disappeared,' she recalls.
'Within three months I'd dropped two stone, going down to my regular weight of eight stone and a dress size 8.'
Michelle tells how she managed to maintain her weight loss until she gave up vaping in the summer of 2022.
'I began to replace vaping with food,' she explains.
Weight Loss Jabs - Pros vs Cons
'The weight started to creep back on. I'm a petite 5ft2 so a few extra pounds really show on me.
'I panicked and looked online for the same Ozempic pens. But this time I couldn't find any pharmacies with any in stock.'
Desperate, in September 2023, she searched on Facebook and saw a company selling them.
'I paid £150 through Paypal, and two days later got a month's supply,' she recalls.
'I could have died'
"They looked exactly the same, apart from the needles being separate. I injected around 16 clicks, but the vial barely went down. I put it back in the fridge - then everything went black.'
Luckily, her daughter Cadie, 13, unexpectedly came home from her dad's house, and spotted her mum sweating and confused.
6
6
6
'Everything went black and I collapsed on the living room floor,' she continues.
'She called my friend Victoria, who dialled 999. Paramedics battled for 90 minutes to stabilise me, eventually reviving me in hospital.
'My blood sugar level was 0.2 – near death! Healthy blood sugar should be between 4 and 7.'
Terrifyingly, doctors later tested the pen and it was full of insulin, Michelle says.
'I could have died,' she adds, choking back tears.
'My daughter could've found me dead on the floor. That thought haunts me to this day.'
There's no quick fix to losing weight, it's all about making sensible decisions and regularly going to the gym and eating a balanced diet
Today, Michelle is a healthy size 8-10, fluctuating between 9st and 9.5st.
'I'm much healthier,' she explains.
'There's no quick fix to losing weight, it's all about making sensible decisions and regularly going to the gym and eating a balanced diet.
'I'd never touch skinny jabs again - fake or otherwise - and want people to know the dangers.
"If I can stop one person from using them, then sharing my story is worth it.'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
29 minutes ago
- Sky News
Millions to receive NHS screening invitations and appointment reminders on their phones
Appointment reminders, invitations to health screenings and test results will now be received by patients on their phones. The government says moving to a more digital-focused NHS will mean 50 million fewer letters need to be sent out by the health service, saving an estimated £200m over the next three years. Instead, under the new plans, millions of people will be notified about appointments and other important notices via the NHS app on their phone or digital device. The app is set to become the go-to method for the NHS to communicate with people, the Department of Health and Social Care said. The changes will be backed by more than £50m investment. It will see a predicted 270 million messages sent through the app this year, an increase of around 70 million on the last financial year, the government announced. Wes Streeting has said this is all about modernising, as the NHS "feels so 20th century". The health secretary said: "The fact that people still get letters through the front door, sometimes multiple letters about the same appointment... The NHS has been stuck in the mud when it comes to the everyday technology we use to organise our lives. And that's why what we're doing with the NHS app is really exciting." Mr Streeting said the app will make using the NHS more convenient, and give patients more control, while saving money. He said these funds can then be invested back into the health service, to bolster things such as frontline care. Using the NHS app should be 'as joyful as Netflix' The modernisation of the NHS will also lead to fewer missed appointments, and therefore save money that way too, it is hoped. In 2023/24, there were around eight million missed appointments in elective care and almost one in three people missed a screening appointment. Currently, around 20 million people have opted in to receive messages from the NHS app. 4:01 Pushed on how the government will ensure that nobody is left behind, Mr Streeting said: "If someone like me is booking my appointment through the app because that's what I prefer to do, [then] that's freeing up a phone line for someone who wants to get through and talk to a person." He added that greater use of the app will give people more choice in "how you want to organise your care". The cabinet minister also made a bold comparison, saying he wishes that the NHS app is as enjoyable as using streaming giant Netflix. He said: "The NHS app actually has more subscribers than Netflix. It would be a really wonderful thing if using the NHS app felt - if not as joyful - almost as joyful as using Netflix." Other features in the pipeline - though not yet available - include being able to add appointments to phone calendars and request help from local GPs on the app. Faster log in methods, such as using Face ID, are also planned.
Daily Mail
40 minutes ago
- Daily Mail
Statins almost halve the risk of death in patients critically ill with sepsis
Taking statins can improve the chances of surviving sepsis by 40 per cent, a trial has found. Sepsis can occur when the body's immune system overreacts to an infection and attacks its own organs. It is notoriously difficult to spot because the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins lower cholesterol to prevent heart attacks and strokes and are taken by around 5 million adults in the UK. But experts say they have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent (file image) In intensive care, 14.3 per cent of 6,000 sepsis patients given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. For those no longer in a critical condition, 11 per cent given statins died compared to 19 per cent who were not. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Researchers believe the drugs may help with sepsis by helping to combat bacteria directly, reducing the toll infection takes on the body. Earlier this year another study found the pills could also slash dementia risk – even in patients who don't have high cholesterol. The sepsis study, published in the journal Frontiers in Immunology, was based on data from thousands of patients at an Israeli hospital over a decade. Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'This study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Sepsis is known as the 'silent killer'. For every hour of delay in treatment, a patient's chance of dying increases 8 per cent. If caught early, it can be treated with antibiotics and fluids. Symptoms include slurred speech or confusion, shivering or muscle pain, passing no urine in a day, severe breathlessness and mottled or discoloured skin. Blood test to spot Alzheimer's early A Blood test for Alzheimer's can accurately detect the disease early, a study suggests. The test was 95 per cent accurate in identifying people with memory problems. It also scored 82 per cent for specificity, which means it was highly accurate in ruling out people without dementia. The study, published in the journal Alzheimer's and Dementia, found proteins amyloid beta 42/40 and p-tau217 in blood plasma can be examined to diagnose the condition. The study was carried out on more than 500 people in an outpatient memory clinic. The blood test has already been approved by the Food and Drug Administration regulator in the US.
Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE Exposed: 'DIY Ozempic' sellers putting lives at risk by peddling super cheap but super dangerous self-mixing weight loss drugs in booming black market
Cheap 'Do It Yourself Ozempic' is being sold across Britain in a booming black market that puts lives at risk, a Daily Mail investigation has found. Scores of dealers based in the UK and China are using social media to openly advertise their cut-price illegal fat jabs to vulnerable people.
